Compuscript Ltd May 24 2026 A new review article is drawing attention to the growing global impact of human papillomavirus (HPV) and the rapid progress in vaccines and therapeutic strategies aimed at reducing the burden of cervical and non-cervical cancers. The article highlights how evolving approaches are reshaping prevention, treatment, and long-term disease management. HPV remains a leading cause of multiple cancers, including cervical, anal, oropharyngeal, and genital malignancies,